BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35880939)

  • 1. Current State of Cell Therapies for Genitourinary Malignancies.
    Alkhouli MA; Bazargan S; Pilon-Thomas S; Poch M; Chahoud J
    Cancer J; 2022 Jul-Aug 01; 28(4):294-300. PubMed ID: 35880939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel immunotherapies in GU malignancies.
    Drakaki A; McDermott DF
    Curr Oncol Rep; 2013 Jun; 15(3):224-31. PubMed ID: 23519772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
    Bigot F; Bonnet C; Massard C
    Bull Cancer; 2017 Apr; 104(4):370-379. PubMed ID: 28237355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies.
    Surolia I; Gulley J; Madan RA
    Expert Opin Biol Ther; 2014 Dec; 14(12):1769-81. PubMed ID: 25212872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Landscape of Immunotherapy in Genitourinary Malignancies.
    Ravindranathan D; Alhalabi O; Rafei H; Shah AY; Bilen MA
    Adv Exp Med Biol; 2021; 1342():143-192. PubMed ID: 34972965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of immunotherapy in clinical management of genitourinary cancers - a review.
    Mar N; Uchio E; Kalebasty AR
    Cancer Treat Res Commun; 2022; 31():100564. PubMed ID: 35472699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in Genitourinary Malignancy: Evolution in Revolution or Revolution in Evolution.
    Lu K; Chiu KY; Cheng CL
    Cancer Treat Res; 2022; 183():201-223. PubMed ID: 35551661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of radiation and immunotherapy in the treatment of genitourinary malignancies: A systematic review and meta-analysis.
    Maisch P; Koll F; Bolenz C; Chun FK; Gschwend JE; Schmid SC
    Urol Oncol; 2023 May; 41(5):219-232. PubMed ID: 36372634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Landscape of Immunotherapy in Genitourinary Malignancies.
    Alhalabi O; Rafei H; Bilen MA; Shah AY
    Adv Exp Med Biol; 2020; 1244():107-147. PubMed ID: 32301013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genitourinary cancers updates: highlights from ASCO 2023.
    Qin Q; Sheffield H; Taasan SM; Wang AZ; Zhang T
    J Hematol Oncol; 2023 Nov; 16(1):112. PubMed ID: 37990343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint inhibitors in genitourinary malignancies.
    Thana M; Wood L
    Curr Oncol; 2020 Apr; 27(Suppl 2):S69-S77. PubMed ID: 32368176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for genitourinary tumors.
    Nakayama T; Kitano S
    Int J Urol; 2019 Mar; 26(3):326-333. PubMed ID: 30710374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination immunotherapy in genitourinary malignancies.
    Hoffman-Censits J; Wilde L
    Curr Opin Urol; 2016 Nov; 26(6):523-8. PubMed ID: 27517637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immuno-Oncology Advances in Genitourinary Cancers.
    Zang PD; Angeles A; Dorff TB; Pal SK; Gupta S
    Am Soc Clin Oncol Educ Book; 2024 Jan; 44(2):e430428. PubMed ID: 38206274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Microbiome and Genitourinary Cancer: A Collaborative Review.
    Markowski MC; Boorjian SA; Burton JP; Hahn NM; Ingersoll MA; Maleki Vareki S; Pal SK; Sfanos KS
    Eur Urol; 2019 Apr; 75(4):637-646. PubMed ID: 30655087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genitourinary cancers in older adults.
    Morganstern D; Garnick MB
    Clin Geriatr Med; 1998 May; 14(2):333-65. PubMed ID: 9536109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genitourinary Cancer: Updates on Treatments and Their Impact on the Kidney.
    Orozco Scott P; Deshpande P; Abramson M
    Semin Nephrol; 2022 Nov; 42(6):151344. PubMed ID: 37172546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of immunotherapy in the treatment of bladder and renal cell carcinoma.
    Stone NN; Droller MJ
    Semin Surg Oncol; 1991; 7(4):239-43. PubMed ID: 1925256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving immunotherapeutic strategies in bladder and renal cancer.
    Griffiths TR; Mellon JK
    Postgrad Med J; 2004 Jun; 80(944):320-7. PubMed ID: 15192163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies.
    Ukleja J; Kusaka E; Miyamoto DT
    Front Oncol; 2021; 11():663852. PubMed ID: 34041029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.